a.novak
TL2 · Cali
Contributes reviews on supplier material. Based in Cali.
Joined 10 August 2025 · last posted 20h
64 posts, newest first. Showing up to 150.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #113 · Start Here › Welcome · 27 Jul 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Submitting a sample: the process end to end Replied, post #107 · Sourcing › Independent verification · 24 Jul 2026 · 0 likes Post #103 describes the usual case. This is about the unusual one. Submitting a sample has a well-known answer and a correct answer, and the interesting work is…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #29 · Access › Insurance & coverage · 15 Jul 2026 · 31 likes Narrowing post #26, because the general version has more than one answer. What I want from this Prior authorisation thread is the list of things that would need to be…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #46 · Analytics › Home & field testing · 6 Jul 2026 · 12 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Coming back to: Storing in the door of the fridge is worse than you think Replied, post #5 · Practice › Storage & stability · 25 Jun 2026 · 28 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment.
-
Semaglutide and alcohol: what is actually documented Replied, post #9 · Compounds › Semaglutide · 12 Jun 2026 · 2 likes Post #8 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #133 · Practice › Storage & stability · 12 Jun 2026 · 7 likes The two questions that get merged here are whether material is degraded and whether it is contaminated. Storage affects both and they need different answers and…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #71 · Practice › Administration · 8 Jun 2026 · 1 like Post #69 describes the usual case. This is about the unusual one. Taking Pinch seriously for a moment rather than deflecting: the honest position is that the community…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #8 · Access › Insurance & coverage · 5 Jun 2026 · 0 likes Prior authorisation was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #24 · Analytics › Mass spectrometry · 5 May 2026 · 0 likes Where I part company with post #20, and it is a narrow parting. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it…
-
The "under review" status pill and when a moderator applies it Replied, post #101 · Evidence › Preprints · 28 Apr 2026 · 4 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. Nothing above should be…
-
The "under review" status pill and when a moderator applies it Replied, post #83 · Evidence › Preprints · 19 Apr 2026 · 6 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. On…
-
Research-use-only status: what it means legally and practically Replied, post #28 · Compounds › Other compounds · 15 Apr 2026 · 9 likes Taking research-use-only status seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
The "under review" status pill and when a moderator applies it Replied, post #68 · Evidence › Preprints · 12 Apr 2026 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #62 · Research Methods › N-of-1 designs · 6 Apr 2026 · 0 likes Picking up post #59: that is the part I would want checked first. It does not tell you about anybody else, which is why aggregating these accounts does not produce…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #4 · Research Methods › N-of-1 designs · 4 Apr 2026 · 2 likes Useful. I have added it to my own notes with the date on it.
-
Managing an unplanned gap in supply Replied, post #70 · Access › Shortages · 23 Mar 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Contributing data without breaching anyone's privacy Replied, post #45 · Data & Tools › Datasets · 5 Mar 2026 · 11 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #12 · Outcomes › Progress reports · 24 Feb 2026 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Maintenance series are the ones this subcategory needs most and receives least. The…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #23 · Access › International · 7 Feb 2026 · 3 likes Post #20 is the version of this I will quote in future. One addition. Availability, approval and reimbursement are three separate questions and a country can be in a…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #30 · Clinical › Special populations · 1 Feb 2026 · 3 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #19 · Sourcing › Logistics · 9 Jan 2026 · 28 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #118 · Compounds › Oral incretins · 29 Dec 2025 · 0 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #30 · Analytics › Impurities & related substances · 28 Dec 2025 · 32 likes Confirming post #29 from a second method, which matters more than confirming it from a second person. Deletion sequences arise from incomplete coupling and are lower by…
-
Reading SURMOUNT-1 without the press release Replied, post #117 · Compounds › Tirzepatide · 27 Dec 2025 · 6 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Documentation that appears only after payment Replied, post #117 · Sourcing › Red flags · 25 Dec 2025 · 0 likes Documentation is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #86 · Compounds › Tirzepatide · 12 Dec 2025 · 0 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #16 · Clinical › Bloodwork · 24 Nov 2025 · 3 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #99 · Start Here › How to Ask · 15 Nov 2025 · 1 like Post #98 answers the question as asked. The question underneath it is different. The specific question in the title is more useful than you might think. A title like "a…
-
Adolescents: a distinct evidence base — one year on Replied, post #29 · Clinical › Special populations · 29 Oct 2025 · 0 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
-
Run-in periods and the population they select Replied, post #4 · Evidence › Trials · 25 Sep 2025 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Nothing in a trial report is medical advice about an individual, and the gap between…
-
Thyroid function tests during substantial weight change Replied, post #71 · Clinical › Bloodwork · 23 Sep 2025 · 16 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #24 · Data & Tools › Datasets · 23 Sep 2025 · 0 likes Date every record. A dataset assembled over two years without dates cannot distinguish a change over time from a change in who was contributing.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #23 · Analytics › COA interpretation · 21 Aug 2025 · 6 likes On post #21 — agreed on the reasoning, with one qualification. The fields that make one usable: lot identifier matching the container, test date, method identification…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #74 · Compounds › Oral incretins · 1 Aug 2025 · 21 likes Building on post #73 rather than restating it. Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #35 · Practice › Reconstitution · 24 Jul 2025 · 21 likes The arithmetic in post #32 is right; the assumption feeding it is the part to check. Over-dilution: I have looked for the primary source twice and failed twice. Either…
-
Journal club: STEP 8 and the fairness of the comparator dose Started this topic · Evidence › Journal club · 21 Jul 2025 · 1 like Journal club: STEP 8 and the fairness of the comparator dose — setting out what I have, and where I think it stops being reliable. Session topic: STEP 8 ( JAMA , 2022).…
-
A field-by-field walk through a certificate of analysis Replied, post #116 · Analytics › COA interpretation · 17 Jul 2025 · 7 likes The question underneath field-by-field walk through a certificate is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #71 · Evidence › Trials · 7 Jul 2025 · 0 likes Taking post #70 at face value and following it one step further. An open-label trial is not worthless and its subjective endpoints deserve more scepticism than its…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #30 · Evidence › Journal club · 17 Jun 2025 · 26 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Two sources, same…
-
A ten-fold dose error caught before injection Replied, post #49 · Devices › Syringes & needles · 14 Jun 2025 · 29 likes Answering the question post #46 raises rather than the one it answers. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger…
-
Coverage for the indication versus for the drug Replied, post #72 · Access › Insurance & coverage · 19 May 2025 · 0 likes Checked the coverage claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #108 · Practice › Reconstitution · 17 May 2025 · 0 likes Picking up post #106: that is the part I would want checked first. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Metformin co-administration and additive GI effects Replied, post #27 · Practice › Interactions · 1 May 2025 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
[2026 update] Splitting an overlong document into two Replied, post #2 · Documentation › Wiki requests · 1 May 2025 · 31 likes Adding a data point of agreement rather than a data point.
-
Units, standards, and other things that quietly hold the world together Replied, post #27 · Lounge › Off topic · 24 Apr 2025 · 7 likes Partly history and partly that nobody had to agree. Purity, assay, content and potency are used interchangeably in commercial documents and mean four different things…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #35 · Evidence › Journal club · 18 Apr 2025 · 17 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Certificates issued by the seller versus by a laboratory Replied, post #40 · Analytics › COA interpretation · 11 Apr 2025 · 22 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Carryover and the ghost peak from last week's standard Replied, post #54 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 16 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 6 Apr 2025 · 12 likes The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2 established that the combination does something; the size of it in…
-
Deamidation and the close-eluting pair it produces Replied, post #13 · Analytics › Impurities & related substances · 23 Mar 2025 · 4 likes Sensible. I would want the same detail before I acted on it either.
-
Maintainer handover: how it works Replied, post #18 · Meta › Wiki maintenance · 14 Mar 2025 · 0 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
-
Requesting a page: what makes a good request Replied, post #15 · Documentation › Wiki requests · 6 Mar 2025 · 6 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #16 · Outcomes › Progress reports · 11 Feb 2025 · 13 likes Post #13 is right about the mechanism and I think understates the practical bit. Protein intake and resistance training: both self-reported and therefore optimistic in…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #72 · Analytics › COA interpretation · 28 Jan 2025 · 15 likes Post #68 and I disagree about the size of the effect, not about the direction. An itemised related-substances table with retention times says considerably more about…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #27 · Practice › Dosing & titration · 20 Jan 2025 · 0 likes What I would tell a new member reading about escalating every six weeks instead for the first time: the confident posts are not the reliable ones, and the reliable ones…
-
Recovery when intake is low: what to cut first Replied, post #23 · Nutrition & Training › Resistance training · 10 Jan 2025 · 11 likes Adding the boring version of recovery, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
-
[2026 update] EU-wide position versus national implementation Replied, post #2 · marked as the solution · Regional › European Union · 30 Dec 2024 · 7 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Anyone quoting an eligibility threshold should cite the national document,…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #32 · Sourcing › Red flags · 29 Dec 2024 · 23 likes Post #31 answers the question as asked. The question underneath it is different. A stock listing that never changes and a lead time that never varies are both worth…
-
UK access routes, dated and sourced — a second dataset Replied, post #13 · Regional › UK & Ireland · 5 Dec 2024 · 0 likes Where I part company with post #9, and it is a narrow parting. Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #118 · Compounds › Repair & healing peptides · 22 Nov 2024 · 9 likes Coming back to post #116, because the follow-up matters more than the original answer. The lyophilised cake is worth looking at before adding diluent. A collapsed or…
-
Why "any advice?" is the least effective ending for a post Replied, post #52 · Start Here › How to Ask · 19 Nov 2024 · 8 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Telehealth prescribing models in the US Replied, post #19 · Regional › North America · 4 Nov 2024 · 0 likes Adding the measurement that post #18 says would settle it. Prior authorisation criteria are usually published by the payer and reading them before the appointment…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #21 · Compounds › Retatrutide · 6 Sep 2024 · 8 likes Trying to state the hepatic effects of glucagon receptor position in a way that someone who disagrees would recognise as fair, because I do not think the version in…